$275,580Aug 11, 2026
SAGENT PHARMACEUTICALS, INC
6505--SAGENT - CIPROFLOXACIN 400 MG/200ML-D5W - BASE+4
View on SAM.gov → · Award 36C77026P0086 · Award Notice
Recent federal contract awards
156 awards in the U.S. signed in the last 90 days, worth $22,539.3M in total. Every item links to the official record.
Who is winning this work
| Recipient | Awards | Total |
|---|---|---|
| Takeda Pharmaceuticals America, Inc. | 2 | $11,200.0M |
| SUMITOMO PHARMA AMERICA, INC. | 2 | $5,790.7M |
| BAUSCH HEALTH US LLC | 1 | $3,680.0M |
| ALNYLAM PHARMACEUTICALS, INC. | 1 | $387.8M |
| DECIPHERA PHARMACEUTICALS, LLC | 2 | $367.6M |
| VIVUS LLC | 1 | $285.7M |
| DAIICHI SANKYO, INC | 1 | $250.0M |
| COLLEGIUM PHARMACEUTICAL INC | 1 | $143.6M |
| LUNDBECK LLC | 1 | $76.0M |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $76.0M |
Top recipients by total obligated amount for this filter. D&B-restricted records are left out.
$5,600.0MAug 7, 2026
Takeda Pharmaceuticals America, Inc.
6505--Takeda Pharmaceuticals America, Inc. - Contract Award: 8/15/2026 - 8/14/2031
View on SAM.gov → · Award 36F79726D0181 · Award Notice
$5,600.0MAug 7, 2026
Takeda Pharmaceuticals America, Inc.
6505--Takeda Pharmaceuticals America, Inc. - Contract Award: 8/15/2026 - 8/14/2031
View on SAM.gov → · Award 36F79726D0181 · Award Notice
$47.3MAug 7, 2026
ABEONA THERAPEUTICS INC.
6505--Abeona Therapeutics Inc. Effective: 08-15-2026 - 08-14-2031
View on SAM.gov → · Award 36F79726D0171 · Award Notice
$891,650Aug 5, 2026
Novartis Pharmaceuticals Corporation
6505--ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063
View on SAM.gov → · Award 36F79720D018036C25526N0394 · Award Notice
$1.9MJul 20, 2026
Also as JSON. USAspending publishes Defense awards about 90 days after signing.